Peter Roos

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Variably protease-sensitive prionopathy with methionine homozygosity at codon 129 in the prion protein gene.

Variably protease-sensitive prionopathy with methionine homozygosity at codon 129 in the prion protein gene.

Journal: BMJ case reports

Published: February 22, 2024

Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation.

Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: September 01, 2022

Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.

Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.

Journal: Acta neurologica Scandinavica

Published: June 23, 2021

Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report.

Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report.

Journal: Clinical medicine insights. Case reports

Published: May 26, 2021

Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia.

Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia.

Journal: Frontiers in aging neuroscience

Published: May 24, 2021

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.

Journal: Dementia and geriatric cognitive disorders

Published: November 09, 2020

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study.

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study.

Journal: Translational psychiatry

Published: September 12, 2019

Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.

Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.

Journal: Journal of Alzheimer's disease : JAD

Published: April 09, 2019

Inflammatory markers of CHMP2B-mediated frontotemporal dementia.

Inflammatory markers of CHMP2B-mediated frontotemporal dementia.

Journal: Journal of neuroimmunology

Published: May 16, 2018

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers.

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers.

Journal: Neurology

Published: May 21, 2017

TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).

TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).

Journal: Neurobiology of aging

Published: July 20, 2016

SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.

SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.

Journal: Cerebellum (London, England)

Published: February 13, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026